Laura H Rosenberger1,2, Samantha M Thomas2,3, Suniti N Nimbkar4, Tina J Hieken5, Kandice K Ludwig6, Lisa K Jacobs7, Megan E Miller8, Kristalyn K Gallagher9, Jasmine Wong10, Heather B Neuman11, Jennifer Tseng12, Taryn E Hassinger13, Tari A King4, James W Jakub5. 1. Department of Surgery, Duke University Medical Center, Durham, NC. 2. Duke Cancer Institute, Duke University, Durham, NC. 3. Biostatistics and Bioinformatics, Duke University, Durham, NC. 4. Brigham & Women's Hospital, Dana-Farber Cancer Institute, Boston, MA. 5. Department of Surgery, Mayo Clinic, Rochester, MN. 6. Department of Surgery, Indiana University School of Medicine, Indianapolis, IN. 7. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. 8. Department of Surgery, University Hospitals, Case Western Reserve University School of Medicine, Cleveland, OH. 9. Department of Surgery, University of North Carolina, Chapel Hill, NC. 10. Department of Surgery, University of California, San Francisco, San Francisco, CA. 11. Department of Surgery, University of Wisconsin, Madison, WI. 12. Department of Surgery, University of Chicago Medicine, Chicago, IL. 13. Department of Surgery, University of Virginia Health System, Charlottesville, VA.
Abstract
PURPOSE: Phyllodes tumors (PTs) are rare breast neoplasms, which have little granular data on margins. Current guidelines recommend ≥ 1 cm margins; however, recent data suggest narrower margins are sufficient, and for benign PT, a negative margin may not be necessary. METHODS: We performed an 11-institution contemporary (2007-2017) review of PT practices. Demographics, surgical, and histopathologic data were captured. Logistic regression was used to estimate the association of select covariates with local recurrence (LR). RESULTS: Of 550 PT patients, the majority underwent excisional biopsy (55.3%, n = 302/546) or lumpectomy (wide excision) (38.5%, n = 210/546). Median tumor size was 30 mm, 68.9% (n = 379) were benign, 19.6% (n = 108) borderline, and 10.5% (n = 58) malignant. Surgical margins were positive in 42% (n = 231) and negative in 57.3% (n = 311). A second operation was performed in 38.0% (n = 209) of the total cohort, including 51 patients with an initial negative margin (82.4% with < 2 mm), and 157 with an initial positive margin, with residual disease only found in six (2.9%). Notably, 32.0% (n = 74) of those with an initial positive margin did not undergo a second operation, among whom only 2.7% (n = 2) recurred. Recurrence occurred in 3.3% (n = 18) of the total cohort (n = 15 LR, n = 3 distant), at median follow-up of 36.7 months. LR (all PT grades) was not reduced with wider negative margin width (≥ 2 mm v < 2 mm: odds ratio [OR] = 0.39; 95% CI, 0.07 to 2.10; P = .27) or final margin status (positive v negative: OR = 0.96; 95% CI, 0.26 to 3.52; P = .96). CONCLUSION: In current practice, many patients are managed outside of current guidelines. For the entire cohort, a wider margin width was not associated with a reduced risk of LR. We do not recommend re-excision of a negative margin for benign PT, regardless of margin width, as a progressively wider surgical margin is unlikely to reduce LR.
PURPOSE: Phyllodes tumors (PTs) are rare breast neoplasms, which have little granular data on margins. Current guidelines recommend ≥ 1 cm margins; however, recent data suggest narrower margins are sufficient, and for benign PT, a negative margin may not be necessary. METHODS: We performed an 11-institution contemporary (2007-2017) review of PT practices. Demographics, surgical, and histopathologic data were captured. Logistic regression was used to estimate the association of select covariates with local recurrence (LR). RESULTS: Of 550 PT patients, the majority underwent excisional biopsy (55.3%, n = 302/546) or lumpectomy (wide excision) (38.5%, n = 210/546). Median tumor size was 30 mm, 68.9% (n = 379) were benign, 19.6% (n = 108) borderline, and 10.5% (n = 58) malignant. Surgical margins were positive in 42% (n = 231) and negative in 57.3% (n = 311). A second operation was performed in 38.0% (n = 209) of the total cohort, including 51 patients with an initial negative margin (82.4% with < 2 mm), and 157 with an initial positive margin, with residual disease only found in six (2.9%). Notably, 32.0% (n = 74) of those with an initial positive margin did not undergo a second operation, among whom only 2.7% (n = 2) recurred. Recurrence occurred in 3.3% (n = 18) of the total cohort (n = 15 LR, n = 3 distant), at median follow-up of 36.7 months. LR (all PT grades) was not reduced with wider negative margin width (≥ 2 mm v < 2 mm: odds ratio [OR] = 0.39; 95% CI, 0.07 to 2.10; P = .27) or final margin status (positive v negative: OR = 0.96; 95% CI, 0.26 to 3.52; P = .96). CONCLUSION: In current practice, many patients are managed outside of current guidelines. For the entire cohort, a wider margin width was not associated with a reduced risk of LR. We do not recommend re-excision of a negative margin for benign PT, regardless of margin width, as a progressively wider surgical margin is unlikely to reduce LR.
Authors: J M Birch; R D Alston; R J McNally; D G Evans; A M Kelsey; M Harris; O B Eden; J M Varley Journal: Oncogene Date: 2001-08-02 Impact factor: 9.867
Authors: Philip M Spanheimer; Melissa P Murray; Emily C Zabor; Michelle Stempel; Monica Morrow; Kimberly J Van Zee; Andrea V Barrio Journal: Ann Surg Oncol Date: 2019-02-19 Impact factor: 5.344
Authors: Harold J Leraas; Laura H Rosenberger; Yi Ren; Brian Ezekian; Uttara P Nag; Christopher R Reed; Samantha M Thomas; Eun-Sil Shelley Hwang; Elisabeth T Tracy Journal: J Pediatr Surg Date: 2018-03-07 Impact factor: 2.545
Authors: Lily Gutnik; Yi Ren; Samantha M Thomas; Jennifer K Plichta; Rachel A Greenup; Oluwadamilola M Fayanju; E Shelley Hwang; Laura H Rosenberger Journal: J Surg Oncol Date: 2022-02-18 Impact factor: 3.454